We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

82 hedge funds and large institutions have $303M invested in Oxford Immunotec Global PLC Ordinary Shares in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 30

1% less funds holding

Funds holding: 83 → 82 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

22% less capital invested

Capital invested by funds: $390M → $303M (-$86.3M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
82
Holders Change
-1
Holders Change %
-1.2%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
32
Reduced
30
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FLAM
First Light Asset Management
Minnesota
+$14M
2
Man Group
Man Group
United Kingdom
+$2.63M
3
ECM
Endurant Capital Management
California
+$2.52M
4
CCM
Consonance Capital Management
New York
+$1.98M
5
MAM
Martingale Asset Management
Massachusetts
+$1.78M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$17.6M
2
WA
Wasatch Advisors
Utah
-$7.85M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$4.28M
4
CWG
C WorldWide Group
Denmark
-$2.58M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$1.66M +$336K +22,124 +21%
Millennium Management
27
Millennium Management
New York
$1.51M +$965K +63,617 +117%
MAM
28
Martingale Asset Management
Massachusetts
$1.5M +$1.78M +117,212 New
OAM
29
Oxford Asset Management
United Kingdom
$1.5M +$521K +34,336 +42%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$1.3M +$212K +13,974 +16%
TIM
31
Triodos Investment Management
Netherlands
$1.28M – – –
Morgan Stanley
32
Morgan Stanley
New York
$1.25M +$811K +53,498 +120%
KCM
33
Kennedy Capital Management
Missouri
$1.24M -$3.2K -211 -0.2%
Russell Investments Group
34
Russell Investments Group
United Kingdom
$1.21M +$123K +8,082 +9%
Deutsche Bank
35
Deutsche Bank
Germany
$1.21M -$232K -15,318 -14%
Vanguard Group
36
Vanguard Group
Pennsylvania
$1.21M -$20.4K -1,345 -1%
BA
37
Boston Advisors
Massachusetts
$1.11M +$116K +7,645 +10%
KCM
38
Kornitzer Capital Management
Kansas
$1.03M – – –
BC
39
Birchview Capital
Vermont
$1.03M -$303K -20,000 -20%
Neuberger Berman Group
40
Neuberger Berman Group
New York
$1.02M – – –
TA
41
Teachers Advisors
New York
$1.02M +$79.6K +5,247 +7%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$992K +$53.1K +3,500 +5%
OC
43
Oppenheimer & Co
New York
$900K +$1.07M +70,400 New
Bank of New York Mellon
44
Bank of New York Mellon
New York
$895K -$6.08K -401 -0.6%
Two Sigma Investments
45
Two Sigma Investments
New York
$881K -$531K -35,003 -34%
Bessemer Group
46
Bessemer Group
New Jersey
$778K +$924K +60,900 New
Citadel Advisors
47
Citadel Advisors
Florida
$721K -$429K -28,280 -33%
Charles Schwab
48
Charles Schwab
California
$650K +$47.7K +3,144 +7%
SIM
49
Spark Investment Management
New York
$619K -$420K -27,700 -36%
Wells Fargo
50
Wells Fargo
California
$615K +$35.3K +2,330 +5%
1
2
3 4

OXFD Hedge Fund Activity: Q4 2018 in Review

82 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2018, worth a combined $303M — down 22% from $390M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of OXFD and 9 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 32 added.

The largest buyer was First Light Asset Management, adding an estimated $14M. The largest seller was Deerfield Management, exiting entirely with an estimated $17.6M sold.

  • 82 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2018, down from 83 in Q3 2018.
  • Funds reported $303M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2018, down 22% quarter-over-quarter.
  • 9 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2018 and 10 closed out, a net change of -1 holder.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2018 was First Light Asset Management, an estimated $14M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2018 was Deerfield Management, an estimated $17.6M sold.

Based on aggregated 13F filings for Q4 2018.